Skip to main content
Top
Published in: BMC Public Health 1/2018

Open Access 01-12-2018 | Research article

Disease awareness campaigns in printed and online media in Latvia: cross-sectional study on consistency with WHO ethical criteria for medicinal drug promotion and European standards

Authors: Teresa Leonardo Alves, Elita Poplavska, Signe Mezinska, Ieva Salmane-Kulikovska, Liga Andersone, Aukje K. Mantel-Teeuwisse, Barbara Mintzes

Published in: BMC Public Health | Issue 1/2018

Login to get access

Abstract

Background

European legislation prohibits direct-to-consumer advertising of prescription medicines, but allows drug manufacturers to provide information to the public on health and diseases. Our aim was to measure the frequency of disease awareness campaigns in Latvian media and assess their compliance with international and European standards.

Methods

Materials on health/disease and treatments were collected between April and September 2015 from 12 newspapers and magazines and six online portals. Disease awareness campaigns were assessed using a previously developed instrument based on the WHO Ethical Criteria for Medicinal Drug promotion and European standards (EU law and pharmaceutical industry self-regulatory guidelines). Collected materials were used to examine the information provided on medical conditions and their diagnosis and treatment. The inter-rater reliability was calculated.

Results

We collected 263 materials from print (n = 149) and online media (n = 114); 94 were news items and 169 were disease-awareness advertisements. Cancer, cardiovascular problems, allergies and respiratory diseases were common topics. Of the 157 campaigns assessed, non-compliance was identified in 149 cases (inter-rater reliability 90%), mainly due to misleading or incomplete information, lack of balance and the absence of a listed author/sponsor. Six disease awareness campaigns directly mentioned a pharmaceutical product by brand name and other four included the logo or name of a manufacturer, referred to a condition and indirectly mentioned a treatment, all in contravention with European law.

Conclusions

The compliance of disease awareness campaigns in Latvian media with international and European standards is low. This raises concerns about the nature of information being conveyed. Through lack of balance, missing sponsorship information, and misleading or incomplete information, these campaigns could contribute to inaccurate self-diagnosis and generate demand among those who might not need medical treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference De Freitas J, Falls BA, Haque OS, Bursztajn HJ. Recognizing misleading pharmaceutical marketing online. J Am Acad Psychiatry Law. 2014;42(2):219–25.PubMed De Freitas J, Falls BA, Haque OS, Bursztajn HJ. Recognizing misleading pharmaceutical marketing online. J Am Acad Psychiatry Law. 2014;42(2):219–25.PubMed
2.
go back to reference Fabius AM, Cheung KC, Rijcken CJ, Vinkers CH, Talsma H. Direct-to-consumer communication on prescription only medicines via the internet in the Netherlands, a pilot study. Opinion of the pharmaceutical industry, patient associations and support groups. Pharm World Sci. 2004;26(3):169–72.CrossRef Fabius AM, Cheung KC, Rijcken CJ, Vinkers CH, Talsma H. Direct-to-consumer communication on prescription only medicines via the internet in the Netherlands, a pilot study. Opinion of the pharmaceutical industry, patient associations and support groups. Pharm World Sci. 2004;26(3):169–72.CrossRef
3.
go back to reference Mansfield P, Mintzes B, Richards D, Toop L. Direct to consumer advertising is at the crossroads of competing pressures from industry and health needs. BMJ: Br Med J (International Edition). 2005;330(7496):5–6.CrossRef Mansfield P, Mintzes B, Richards D, Toop L. Direct to consumer advertising is at the crossroads of competing pressures from industry and health needs. BMJ: Br Med J (International Edition). 2005;330(7496):5–6.CrossRef
4.
go back to reference Stros M, Lee N. Marketing dimensions in the prescription pharmaceutical industry: a systematic literature review. J Strateg Mark. 2015;23(4):318–36.CrossRef Stros M, Lee N. Marketing dimensions in the prescription pharmaceutical industry: a systematic literature review. J Strateg Mark. 2015;23(4):318–36.CrossRef
5.
go back to reference Mackenzie FJ, Jordens CFC, Ankeny RA, McPhee J, Kerridge IH. Direct-to-consumer advertising under the radar: the need for realistic drugs policy in Australia. Intern Med J. 2007;37(4):224–8.CrossRef Mackenzie FJ, Jordens CFC, Ankeny RA, McPhee J, Kerridge IH. Direct-to-consumer advertising under the radar: the need for realistic drugs policy in Australia. Intern Med J. 2007;37(4):224–8.CrossRef
6.
go back to reference Van de Pol PK, de Bakker FG. Direct-to-consumer advertising of pharmaceuticals as a matter of corporate social responsibility? J Bus Ethics. 2010;94(2):211–24.CrossRef Van de Pol PK, de Bakker FG. Direct-to-consumer advertising of pharmaceuticals as a matter of corporate social responsibility? J Bus Ethics. 2010;94(2):211–24.CrossRef
7.
go back to reference Dubois RW. Pharmaceutical promotion: Don’t throw the baby out with the bathwater. Health affairs – web exclusive W3–96–W3–103; 2003. Dubois RW. Pharmaceutical promotion: Don’t throw the baby out with the bathwater. Health affairs – web exclusive W3–96–W3–103; 2003.
8.
go back to reference Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease mongering. Br Med J. 2002;324(7342):886–90.CrossRef Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease mongering. Br Med J. 2002;324(7342):886–90.CrossRef
9.
go back to reference Pathirana T, Clark J, Moynihan R. Mapping the drivers of overdiagnosis to potential solutions. BMJ. 2017;358:j3879.CrossRef Pathirana T, Clark J, Moynihan R. Mapping the drivers of overdiagnosis to potential solutions. BMJ. 2017;358:j3879.CrossRef
10.
go back to reference Moynihan R, Glasziou P, Woloshin S, Schwartz L, Santa J, Godlee F. Winding back the harms of too much medicine. BMJ. 2013;346:f1271.CrossRef Moynihan R, Glasziou P, Woloshin S, Schwartz L, Santa J, Godlee F. Winding back the harms of too much medicine. BMJ. 2013;346:f1271.CrossRef
11.
go back to reference Belisle-Pipon JC, Williams-Jones B. Drug familiarization and therapeutic misconception via direct-to-consumer information. J Bioeth Inq. 2015;12(2):259–67.CrossRef Belisle-Pipon JC, Williams-Jones B. Drug familiarization and therapeutic misconception via direct-to-consumer information. J Bioeth Inq. 2015;12(2):259–67.CrossRef
12.
go back to reference Stremersch S, Van Dyck W. Marketing of the life sciences. A new framework and research agenda for a nascent field. J Mark. 2009;73:4–30.CrossRef Stremersch S, Van Dyck W. Marketing of the life sciences. A new framework and research agenda for a nascent field. J Mark. 2009;73:4–30.CrossRef
13.
go back to reference Sullivan R. Direct-to-consumer advertising: the future in Europe. J R Soc Med. 2000;93(8):400–1.CrossRef Sullivan R. Direct-to-consumer advertising: the future in Europe. J R Soc Med. 2000;93(8):400–1.CrossRef
14.
go back to reference European Parliament and Council: Directive 2004/27/EC of the European Parliament and the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use Directive 2004/27/EC 2004. European Parliament and Council: Directive 2004/27/EC of the European Parliament and the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use Directive 2004/27/EC 2004.
15.
go back to reference Latvia Ro: “Procedures for Advertising Medicinal Products and Procedures by Which a Medicinal Product Manufacturer is Entitled to Give Free Samples of Medicinal Products to Physicians”. Cabinet Regulation No 378 2011, Article 2 (Adopted 17 May). Latvia Ro: “Procedures for Advertising Medicinal Products and Procedures by Which a Medicinal Product Manufacturer is Entitled to Give Free Samples of Medicinal Products to Physicians”. Cabinet Regulation No 378 2011, Article 2 (Adopted 17 May).
17.
go back to reference ‘T Jong G’W, Stricker BHC, Sturkenboom MCJM: Marketing in the lay media and prescriptions of terbinafine in primary care: Dutch cohort study. Br Med J 2004, 328(7445):931.CrossRef ‘T Jong G’W, Stricker BHC, Sturkenboom MCJM: Marketing in the lay media and prescriptions of terbinafine in primary care: Dutch cohort study. Br Med J 2004, 328(7445):931.CrossRef
19.
go back to reference Basara LR. The impact of a direct-to-consumer prescription medication advertising campaign on new prescription volume. Drug Inf J. 1996;30(3):715–29.CrossRef Basara LR. The impact of a direct-to-consumer prescription medication advertising campaign on new prescription volume. Drug Inf J. 1996;30(3):715–29.CrossRef
20.
go back to reference Hall DK, Jones CJ, Iverson DC. Content analysis of disease awareness advertisements in popular Australian women’s magazines. Med J Aust. 2009;191(11–12):625–9.PubMed Hall DK, Jones CJ, Iverson DC. Content analysis of disease awareness advertisements in popular Australian women’s magazines. Med J Aust. 2009;191(11–12):625–9.PubMed
21.
go back to reference Leonardo Alves T, Martins de Freitas AF, van Eijk ME, Mantel-Teeuwisse AK. Compliance of disease awareness campaigns in printed Dutch media with national and international regulatory guidelines. PLoS One. 2014;9(9):e106599.CrossRef Leonardo Alves T, Martins de Freitas AF, van Eijk ME, Mantel-Teeuwisse AK. Compliance of disease awareness campaigns in printed Dutch media with national and international regulatory guidelines. PLoS One. 2014;9(9):e106599.CrossRef
22.
go back to reference World Health Organization. Ethical criteria for medicinal drug promotion: World Health Organization; 1988. World Health Organization. Ethical criteria for medicinal drug promotion: World Health Organization; 1988.
23.
go back to reference Stichting C. Leidraad Informatie UR geneesmiddelen; 2011. Stichting C. Leidraad Informatie UR geneesmiddelen; 2011.
24.
go back to reference OECD: Health policy in Latvia. OECD health policy overview 2017. OECD: Health policy in Latvia. OECD health policy overview 2017.
30.
go back to reference Müller RBP. A critical discussion of intraclass correlation coefficients. Stat Med. 1994;13(23–24):2465–76.CrossRef Müller RBP. A critical discussion of intraclass correlation coefficients. Stat Med. 1994;13(23–24):2465–76.CrossRef
31.
go back to reference Ebeling M. ‘Get with the program!’: pharmaceutical marketing, symptom checklists and self-diagnosis. Soc Sci Med. 2011;73(6):825–32.CrossRef Ebeling M. ‘Get with the program!’: pharmaceutical marketing, symptom checklists and self-diagnosis. Soc Sci Med. 2011;73(6):825–32.CrossRef
32.
go back to reference Sullivan HW, O'Donoghue AC, Rupert DJ, Willoughby JF, Amoozegar JB, Aikin KJ. Are disease awareness links on prescription drug websites misleading? A randomized study. J Health Commun. 2016;21(11):1198–207.CrossRef Sullivan HW, O'Donoghue AC, Rupert DJ, Willoughby JF, Amoozegar JB, Aikin KJ. Are disease awareness links on prescription drug websites misleading? A randomized study. J Health Commun. 2016;21(11):1198–207.CrossRef
33.
go back to reference Doran E, Henry D. Disease mongering: expanding the boundaries of treatable disease. Intern Med J. 2008;38(11):858–61.CrossRef Doran E, Henry D. Disease mongering: expanding the boundaries of treatable disease. Intern Med J. 2008;38(11):858–61.CrossRef
34.
go back to reference Moynihan R, Bero L, Ross-Degnan D, Henry D, Lee K, Watkins J, Mah C, Soumerai S. Coverage by the news media of the benefits and risks of medications. New Engl J Med. 2000;342(22):1645–50.CrossRef Moynihan R, Bero L, Ross-Degnan D, Henry D, Lee K, Watkins J, Mah C, Soumerai S. Coverage by the news media of the benefits and risks of medications. New Engl J Med. 2000;342(22):1645–50.CrossRef
35.
go back to reference Cassels A, Hughes MA, Cole C, Mintzes B, Lexchin J, McCormack JP. Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs. Cmaj. 2003;168(9):1133–7.PubMedPubMedCentral Cassels A, Hughes MA, Cole C, Mintzes B, Lexchin J, McCormack JP. Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs. Cmaj. 2003;168(9):1133–7.PubMedPubMedCentral
36.
go back to reference Prosser H. Marvelous medicines and dangerous drugs: the representation of prescription medicine in the UK newsprint media. Public Underst Sci. 2010;19(1):52–69.CrossRef Prosser H. Marvelous medicines and dangerous drugs: the representation of prescription medicine in the UK newsprint media. Public Underst Sci. 2010;19(1):52–69.CrossRef
37.
go back to reference Mintzes B. Disease mongering in drug promotion: do governments have a regulatory role? PLoS Med. 2006;3(4):e198.CrossRef Mintzes B. Disease mongering in drug promotion: do governments have a regulatory role? PLoS Med. 2006;3(4):e198.CrossRef
38.
go back to reference Kessler DA. Addressing the problem of misleading advertising. Ann Intern Med [0003–4819]. 1992;116(11):950–1.CrossRef Kessler DA. Addressing the problem of misleading advertising. Ann Intern Med [0003–4819]. 1992;116(11):950–1.CrossRef
39.
go back to reference Bhutada NS, Rollins BL. Disease-specific direct-to-consumer advertising for reminding consumers to take medications. J Am Pharm Assoc (2003). 2015;55(4):434–7.CrossRef Bhutada NS, Rollins BL. Disease-specific direct-to-consumer advertising for reminding consumers to take medications. J Am Pharm Assoc (2003). 2015;55(4):434–7.CrossRef
40.
go back to reference Hall DV, Jones SC. Australian consumer responses to DTCA and other pharmaceutical company sponsored advertisements. Aust N Z J Public Health. 2008;32(5):471–8.CrossRef Hall DV, Jones SC. Australian consumer responses to DTCA and other pharmaceutical company sponsored advertisements. Aust N Z J Public Health. 2008;32(5):471–8.CrossRef
41.
go back to reference Parker L, Williams J, Bero L. Ethical drug marketing criteria for the 21st century. BMJ. 2018;361:k1809.CrossRef Parker L, Williams J, Bero L. Ethical drug marketing criteria for the 21st century. BMJ. 2018;361:k1809.CrossRef
42.
go back to reference Inspekcijas V. Veselibas Inspekcijas Publiskais Parskats; 2016. Inspekcijas V. Veselibas Inspekcijas Publiskais Parskats; 2016.
43.
go back to reference Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff (Millwood). 2000;19(2):110–28.CrossRef Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff (Millwood). 2000;19(2):110–28.CrossRef
Metadata
Title
Disease awareness campaigns in printed and online media in Latvia: cross-sectional study on consistency with WHO ethical criteria for medicinal drug promotion and European standards
Authors
Teresa Leonardo Alves
Elita Poplavska
Signe Mezinska
Ieva Salmane-Kulikovska
Liga Andersone
Aukje K. Mantel-Teeuwisse
Barbara Mintzes
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2018
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-018-6202-2

Other articles of this Issue 1/2018

BMC Public Health 1/2018 Go to the issue